Literature DB >> 8991477

Risk factors for fungemia in children infected with human immunodeficiency virus: a case-control study.

C E Gonzalez1, D Venzon, S Lee, B U Mueller, P A Pizzo, T J Walsh.   

Abstract

To define the risk factors related to the occurrence of fungemia in children infected with human immunodeficiency virus (HIV), we performed a matched case-control study. During a 6-year period (1987-1993), fungemia developed in 22 (6.3%) of 347 HIV-infected children observed at the Pediatric Branch of the National Cancer Institute. Each of these 22 cases was matched by age and gender with three controls. Multiple logistic regression indicated that the best predictor of fungemia in this population was the presence of a central venous catheter placed for > 90 days (P < .00001), followed by a group of risk factors composed of 10 independent variables adjusted for a CD4 cell count of < 100/MicroL (P < .045). Those variables included treatment with more than three antibiotics, treatment with more than three parenteral antibiotics, > 30 days of antibiotic treatment, bacterial infections, > 30 days in the hospital, hypoalbuminemia, C3 (Centers for Disease Control and Prevention) classification of HIV infection, and malnourishment. We conclude that prolonged placement of central venous catheters is the most important risk factors for fungemia in HIV-infected children and that the risk of fungemia is further influenced by antibacterial therapy, catheter manipulation, and host response.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8991477     DOI: 10.1093/clinids/23.3.515

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  11 in total

1.  Experience with invasive Candida infections.

Authors:  H Girishkumar; A M Yousuf; J Chivate; E Geisler
Journal:  Postgrad Med J       Date:  1999-03       Impact factor: 2.401

Review 2.  Antifungal prophylaxis during neutropenia and immunodeficiency.

Authors:  O Lortholary; B Dupont
Journal:  Clin Microbiol Rev       Date:  1997-07       Impact factor: 26.132

3.  Antimicrobial activity of some Indian medicinal plants.

Authors:  Rajesh Dabur; Amita Gupta; T K Mandal; Desh Deepak Singh; Vivek Bajpai; A M Gurav; G S Lavekar
Journal:  Afr J Tradit Complement Altern Med       Date:  2007-02-16

4.  Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children: recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics.

Authors:  George K Siberry; Mark J Abzug; Sharon Nachman; Michael T Brady; Kenneth L Dominguez; Edward Handelsman; Lynne M Mofenson; Steve Nesheim
Journal:  Pediatr Infect Dis J       Date:  2013-11       Impact factor: 2.129

5.  Fatal fungemia due to Paracoccidioides lutzii.

Authors:  Rosane Christine Hahn; Anderson Messias Rodrigues; Cor Jesus Fernandes Fontes; Andreia Ferreira Nery; Tomoko Tadano; Luiz de Pádua Queiroz; Zoilo Pires de Camargo
Journal:  Am J Trop Med Hyg       Date:  2014-05-12       Impact factor: 2.345

6.  Non-albicans Candida is the most common cause of candidemia in pediatric cancer patients.

Authors:  C A Mullen; H Abd El-Baki; H Samir; J J Tarrand; K V Rolston
Journal:  Support Care Cancer       Date:  2003-03-11       Impact factor: 3.603

7.  Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics.

Authors:  Lynne M Mofenson; Michael T Brady; Susie P Danner; Kenneth L Dominguez; Rohan Hazra; Edward Handelsman; Peter Havens; Steve Nesheim; Jennifer S Read; Leslie Serchuck; Russell Van Dyke
Journal:  MMWR Recomm Rep       Date:  2009-09-04

8.  Catheter-related Candida bloodstream infection in intensive care unit patients: a subgroup analysis of the China-SCAN study.

Authors:  Bo Hu; Zhaohui Du; Yan Kang; Bin Zang; Wei Cui; Bingyu Qin; Qiang Fang; Haibo Qiu; Jianguo Li
Journal:  BMC Infect Dis       Date:  2014-11-13       Impact factor: 3.090

9.  Free radical scavenging capacity, anticandicidal effect of bioactive compounds from Sida cordifolia L., in combination with nystatin and clotrimazole and their effect on specific immune response in rats.

Authors:  Maurice Ouédraogo; Kiessoun Konaté; Alexis Nicaise Lepengué; Alain Souza; Bertrand M'Batchi; Laya L Sawadogo
Journal:  Ann Clin Microbiol Antimicrob       Date:  2012-12-26       Impact factor: 3.944

10.  New insights into the clinical characteristics and prognostic factors of pulmonary fungal infections from a retrospective study in Southwestern China.

Authors:  Li Peng; Zhiping Xu; Zhenyu Huo; Rui Long; Liang Ma
Journal:  Infect Drug Resist       Date:  2018-03-05       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.